Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7561616rdf:typepubmed:Citationlld:pubmed
pubmed-article:7561616lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:7561616lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:7561616lifeskim:mentionsumls-concept:C0025255lld:lifeskim
pubmed-article:7561616lifeskim:mentionsumls-concept:C0205054lld:lifeskim
pubmed-article:7561616lifeskim:mentionsumls-concept:C0061355lld:lifeskim
pubmed-article:7561616lifeskim:mentionsumls-concept:C1167622lld:lifeskim
pubmed-article:7561616pubmed:issue1lld:pubmed
pubmed-article:7561616pubmed:dateCreated1995-10-25lld:pubmed
pubmed-article:7561616pubmed:abstractTextWe have found [125I]glucagon-like peptide (GLP)-1(7-36)amide specific binding activity in rat liver and isolated hepatocyte plasma membranes, with an M(r) of approximately 63,000, estimated by cross-linking and SDS-PAGE. The specific binding was time- and membrane protein concentration-dependent, and equally displaced by unlabelled GLP-1(7-36)amide and by GLP-1(1-36)amide, achieving its ID50 at 3 x 10(-9) M of the peptides. GLP-1(7-36)amide did not modify the basal or the glucagon (10(-8) M)-stimulated adenylate cyclase in the hepatocyte plasma membranes. These data, together with our previous findings of a potent glycogenic effect of GLP-1(7-36)amide in isolated rat hepatocytes, led us to postulate that the insulin-like effects of this peptide on glucose liver metabolism could be mediated by a type of receptor probably different from that described for GLP-1 in pancreatic B-cells or, alternatively, by the same receptor which, in this tissue as well as in muscle, uses a different transduction system.lld:pubmed
pubmed-article:7561616pubmed:languageenglld:pubmed
pubmed-article:7561616pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7561616pubmed:citationSubsetIMlld:pubmed
pubmed-article:7561616pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7561616pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7561616pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7561616pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7561616pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7561616pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7561616pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7561616pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7561616pubmed:statusMEDLINElld:pubmed
pubmed-article:7561616pubmed:monthJullld:pubmed
pubmed-article:7561616pubmed:issn0022-0795lld:pubmed
pubmed-article:7561616pubmed:authorpubmed-author:ClementsTTlld:pubmed
pubmed-article:7561616pubmed:authorpubmed-author:ValverdeIIlld:pubmed
pubmed-article:7561616pubmed:authorpubmed-author:PerecCClld:pubmed
pubmed-article:7561616pubmed:authorpubmed-author:DelgadoEElld:pubmed
pubmed-article:7561616pubmed:authorpubmed-author:AlcántaraAAlld:pubmed
pubmed-article:7561616pubmed:authorpubmed-author:TrapoteM AMAlld:pubmed
pubmed-article:7561616pubmed:authorpubmed-author:Villanueva-Pe...lld:pubmed
pubmed-article:7561616pubmed:authorpubmed-author:LuqueM AMAlld:pubmed
pubmed-article:7561616pubmed:issnTypePrintlld:pubmed
pubmed-article:7561616pubmed:volume146lld:pubmed
pubmed-article:7561616pubmed:ownerNLMlld:pubmed
pubmed-article:7561616pubmed:authorsCompleteYlld:pubmed
pubmed-article:7561616pubmed:pagination183-9lld:pubmed
pubmed-article:7561616pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:7561616pubmed:meshHeadingpubmed-meshheading:7561616-...lld:pubmed
pubmed-article:7561616pubmed:meshHeadingpubmed-meshheading:7561616-...lld:pubmed
pubmed-article:7561616pubmed:meshHeadingpubmed-meshheading:7561616-...lld:pubmed
pubmed-article:7561616pubmed:meshHeadingpubmed-meshheading:7561616-...lld:pubmed
pubmed-article:7561616pubmed:meshHeadingpubmed-meshheading:7561616-...lld:pubmed
pubmed-article:7561616pubmed:meshHeadingpubmed-meshheading:7561616-...lld:pubmed
pubmed-article:7561616pubmed:meshHeadingpubmed-meshheading:7561616-...lld:pubmed
pubmed-article:7561616pubmed:meshHeadingpubmed-meshheading:7561616-...lld:pubmed
pubmed-article:7561616pubmed:meshHeadingpubmed-meshheading:7561616-...lld:pubmed
pubmed-article:7561616pubmed:meshHeadingpubmed-meshheading:7561616-...lld:pubmed
pubmed-article:7561616pubmed:meshHeadingpubmed-meshheading:7561616-...lld:pubmed
pubmed-article:7561616pubmed:meshHeadingpubmed-meshheading:7561616-...lld:pubmed
pubmed-article:7561616pubmed:meshHeadingpubmed-meshheading:7561616-...lld:pubmed
pubmed-article:7561616pubmed:meshHeadingpubmed-meshheading:7561616-...lld:pubmed
pubmed-article:7561616pubmed:year1995lld:pubmed
pubmed-article:7561616pubmed:articleTitleGlucagon-like peptide-1 binding to rat hepatic membranes.lld:pubmed
pubmed-article:7561616pubmed:affiliationDepartamento Metabolismo, Nutrición y Hormonas, Fundación Jiménez Díaz, Madrid, Spain.lld:pubmed
pubmed-article:7561616pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7561616pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7561616lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7561616lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7561616lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7561616lld:pubmed